We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Acute Streptococcus pneumoniae Meningogenic Labyrinthitis An Experimental Guinea Pig Model and Literature Review

Andrew L. Blank, MD; Gustave L. Davis, MD; Thomas R. VanDeWater, PhD; Robert J. Ruben, MD
Arch Otolaryngol Head Neck Surg. 1994;120(12):1342-1346. doi:10.1001/archotol.1994.01880360040008.
Text Size: A A A
Published online


Objective:  To create an experimental model of Streptococcus pneumoniae type 3 meningogenic labyrinthitis (a leading cause of deafness) similar to that in human disease.

Design:  Cohort analytic study of guinea pigs that were inoculated intrathecally with varying dilutions of S pneumoniae type 3; the progress of the disease was compared with that in saline solution–inoculated control animals.

Subjects:  Healthy adult Hartley guinea pigs without clinical evidence of middle ear disease that were conveniently sampled.

Interventions:  Intrathecal inoculation of 104 to 106 colony-forming units of S pneumoniae type 3 into 13 guinea pigs; signs and symptoms of meningitis/labyrinthitis were observed for 15 days and compared with those in two saline solution–inoculated control animals.

Main Outcome Measures:  Morbidity—labyrinthitis, meningitis; end point—death.

Results:  The 104 to 106 colony-forming units of S pneumoniae type 3 caused inflammation that extended from the meninges to the inner ear via the cochlear aqueduct within 3 days after inoculation; a dose of 107 killed animals within 12 hours after inoculation. Three of five animals that were inoculated with a 106 dose died 3 days after inoculation; two of three animals that were inoculated with a 105 dose lived to 15 days after inoculation. One of two animals that were inoculated with a 104 dose did not become infected. Inflammation extended to the middle ear by round-window destruction. Reactive bone formation simulated labyrinthine osteosclerosis. Observers assessed histologic slides "blindly."

Conclusion:  Guinea pigs can survive 15 days after intrathecal inoculation of a 105 dose, with morphologic features similar to those in human disease. This is an effective model for this study of meningogenic labyrinthitis.(Arch Otolaryngol Head Neck Surg. 1994;120:1342-1346)


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.